Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-15Clinical Trial Update: Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma [Phase 1, Phase 2]
This clinical trial update reports a completed Phase 1/2 study of arsenic trioxide plus vitamin C in patients with recurrent or refractory m…
-
CLINICAL_TRIALS trial_result · 2016-12-09Clinical Trial Update: Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma [NA]
Trial results for epoetin alfa in treating anemia in patients undergoing chemotherapy for multiple myeloma have been posted after completion…
-
CLINICAL_TRIALS trial_result · 2016-12-08Clinical Trial Update: Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder [Phase 3]
Phase 3 trial evaluating cyclosporine eye drops to prevent eye graft-versus-host disease in patients after donor stem cell transplant for he…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Safety and Efficacy Study for the Prevention of Nausea and Vomiting in Multiple Myeloma Patients Receiving Stem Cell Transplantation. [Phase 2]
A Phase 2 trial completed evaluating an antiemetic therapy to prevent nausea and vomiting in multiple myeloma patients undergoing stem cell …
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Clinical Trial of Expanded and Activated Autologous NK Cells to Treat Multiple Myeloma [Phase 1]
Phase 1 trial investigating expanded and activated autologous NK cells for treating multiple myeloma has completed with results posted in 20…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Evaluation of PET/MR and PET/CT Imaging for Bone Marrow Lesions
A completed clinical trial evaluating PET/MR and PET/CT imaging for detecting bone marrow lesions in conditions including multiple myeloma, …
-
CLINICAL_TRIALS trial_result · 2016-12-01Clinical Trial Update: A Study of Doxil, Vincristine and Decadron (DVd) +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM) [Phase 1]
Phase 1 study evaluating Doxil, Vincristine and Dexamethasone with or without CC-5013 (lenalidomide) in relapsed or refractory multiple myel…
-
CLINICAL_TRIALS trial_result · 2016-11-17Clinical Trial Update: Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating eltrombopag for thrombocytopenia in patients with relapsed multiple myeloma was terminated; results were posted in …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Carfilzomib in Treating Patients With Multiple Myeloma in First Relapse or Refractory to First-Line Therapy [Phase 2]
Phase 2 trial evaluating carfilzomib in patients with multiple myeloma in first relapse or refractory to first-line therapy; the study was t…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple Myeloma [Phase 1]
This Phase 1 trial evaluated the safety and pharmacokinetics of MFGR1877S in patients with relapsed or refractory t(4;14)-positive multiple …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating pomalidomide in combination with low-dose dexamethasone for Chinese patients with relapsed and refractory multiple …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of the investigational agent DFRF4539A in patients with relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Acupuncture for Chemo-Induced Peripheral Neuropathy [Phase 2]
Phase 2 trial evaluating acupuncture to treat chemotherapy-induced peripheral neuropathy in patients with lymphoma or multiple myeloma; resu…
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: A Multicenter, Open-label, Phase 1b Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Subjects [Phase 1]
A multicenter, open-label Phase 1b trial examines the combination of carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed mul…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma [Phase 2]
A Phase 2 trial evaluated Zevalin (ibritumomab tiuxetan) for patients with incomplete response to chemotherapy prior to autologous stem cell…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Fungemia in Hematologic Malignancies
This clinical trial update notes the completion of a study on fungemia (fungal bloodstream infections) in patients with hematologic malignan…
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant [Phase 2]
A Phase 2 trial evaluating the impact of a nutritional program during autologous stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients [Phase 2]
A Phase 2 trial evaluating the RAD regimen (lenalidomide, doxorubicin, dexamethasone) in newly diagnosed multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-11Clinical Trial Update: Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function [Phase 2]
Phase 2 pharmacokinetic study of lenalidomide (Revlimid) in patients with multiple myeloma and impaired renal function.
-
CLINICAL_TRIALS trial_result · 2016-10-07Clinical Trial Update: A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of Noscapine HCl (CB3304) in patients with relapsed or refractory multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Safety and Pharmacokinetic Profile of CKD-581 [Phase 1]
This Phase 1 trial evaluated the safety and pharmacokinetic profile of CKD-581 in patients with lymphoma and multiple myeloma. The study has…
-
CLINICAL_TRIALS trial_result · 2016-10-06Clinical Trial Update: Common Safety Follow-up Trial of Tecemotide (L-BLP25) [NA]
The common safety follow-up trial of Tecemotide (L-BLP25) was terminated, with results posted on 2016-10-06.
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy [NA]
A European trial evaluating extended haemodialysis to remove free light chains in myeloma-associated cast nephropathy has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Multiple Ascending Dose (MAD) Combination in Subjects With Multiple Myeloma [Phase 1]
Phase 1 multiple ascending dose trial update of a combination therapy in subjects with multiple myeloma. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-09-28Clinical Trial Update: A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors [Phase 1]
A Phase 1 study of DKN-01 in multiple myeloma or advanced solid tumors has completed enrollment with results posted in 2016.